ZEVRA THERAPEUTICS, INC. — Director's Dealing 2017

Nov 29, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2017-11-27

Reporting Person: Cohen Daniel L (EVP, Govt. & Public Relations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-27	Common Stock	P	1145	$3.70	Acquired	26145	Direct
2017-11-27	Common Stock	P	1310	$3.75	Acquired	27455	Direct
2017-11-27	Common Stock	P	2990	$3.80	Acquired	30445	Direct
2017-11-27	Common Stock	P	2055	$3.85	Acquired	32500	Direct
2017-11-29	Common Stock	G	2500	—	Disposed	30000	Direct
2017-11-29	Common Stock	G	1250	—	Acquired	1250	Indirect
2017-11-29	Common Stock	G	1250	—	Acquired	1250	Indirect

Footnotes

F1: The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account.

F2: The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account.